1-es típusú cukorbetegség: vizsgálatok itt: Szaúd-Arábia
6 trials · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.
- No phaseTaking peopleEarly Detection of Type 1 Diabetes in First Degree Relatives of Type 1 Diabetes Patients (DETECT T1D GULF)
- Where
- Dammam, Jeddah, Riyadh
- Életkor
- 18 hónap to 18 év
- People
- 3500 worldwide
- Run by
- Sanofi
See details and how to joinNCT07038473 - 3. fázisTaking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Riyadh
- Életkor
- 18 év to 65 év
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - 2. fázisNot yet taking people in Szaúd-ArábiaSHIELD-T1D: Shingrix and GLP-1 Agonist for Beta-Cell Preservation in Recent-Onset Type 1 Diabetes.
- Where
- Riyadh
- Életkor
- 18 év to 50 év
- People
- 240
- Run by
- Ministry of Health, Saudi Arabia
See details and how to joinNCT07614412 - 3. fázisTaking peopleAn Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
- Where
- Riyadh
- Életkor
- 18 év to 65 év
- People
- 10 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT06832410 - 4. fázisNot yet taking people in Szaúd-ArábiaCan the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?
- Where
- Riyadh
- Életkor
- 18 év and over
- People
- 60 worldwide
- Run by
- Dasman Diabetes Institute
See details and how to joinNCT06922656 - No phaseTaking peopleScreening Program for Type 1 Diabetes in a High-Risk Population
- Where
- Riyadh
- Életkor
- 2 év to 18 év
- People
- 1300
- Run by
- King Saud University
See details and how to joinNCT06513247